Graham George Adam Inglis

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Graham George Adam Inglis is active.

Explore More

Publication

Featured researches published by Graham George Adam Inglis.

Archive | 2005

2,3-benzoxazin derivatives as non-steroidal glucocorticoid receptor modulators

David House; Graham George Adam Inglis; Michael John Johnston; Haydn Terence Jones; Simon J. F. Macdonald; Philip Alan Skone

Archive | 2005

Substituted oxazines as glucocorticoid receptor modulators

David House; Graham George Adam Inglis; Michael John Johnston; Haydn Terence Jones; Simon J. F. Macdonald; Philip Alan Skone

Archive | 1997

Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase

Michael Dennis Glaxo Wellcome Plc Dowle; Harry Finch; Lee Andrew Glaxo Wellcome Plc Harrison; Graham George Adam Inglis; Martin Redpath Glaxo Wellcome Plc Johnson; Simon John Fawcett Glaxo Wellcome Plc Macdonald; Pritom Shah; Robin Andrew Glaxo Wellcome Plc Smith

Archive | 2004

Non-steroidal infalmmation inhibitors

Michael David Barker; Derek Anthony Demaine; David House; Graham George Adam Inglis; Michael John Johnston; Haydn Terence Jones; Simon J. F. Macdonald; Iain Mcfarlane Mclay; Stephen E. Shanahan; Philip Alan Skone; Maria Victoria Vinader

Archive | 2012

Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditions

Heather Anne Barnett; Ian B. Campbell; Diane Mary Coe; Anthony William James Cooper; Graham George Adam Inglis; Haydn Terence Jones; Steven Philip Keeling; Simon J. F. Macdonald; Iain Mcfarlane Mclay; Philip Alan Skone; Gordon G. Weingarten; James Michael Woolven

Archive | 2002

Intermediates for preparing neuraminidase inhibitor conjugates

Brian David Judkins; Simon J. F. Macdonald; Derek Anthony Demaine; Graham George Adam Inglis; Julie Nicole Hamblin

Archive | 2017

Compuestos de N-(2-(fenil) piridina-4-il)-5-morfolinopiridina-3-sulfonamida como inhibidores de la actividad PL3-quinasa

Anthony William James Cooper; Nicholas Paul Barton; Sebastien Andre Campos; Edward Paul Cannons; Kenneth David Down; Kevin James Doyle; Julie Nicole Hamblin; Graham George Adam Inglis; Armelle Le Gall; Vipulkumar Kantibhai Patel; Peace Simon; Sharpe Andrew; Gemma Victoria White; Niall Andrew Anderson

Archive | 2017

Chemical compounds as inhibitors of kinase activity

Niall Andrew Anderson; Nicholas Paul Barton; Sebastien Andre Campos; Edward Paul Cannons; Anthony William James Cooper; Kenneth David Down; Kevin James Doyle; Julie Nicole Hamblin; Graham George Adam Inglis; Gall Armelle Le; Vipulkumar Kantibhai Patel; Simon Peace; Andrew Sharpe; Gemma Victoria White

Archive | 2007